Results 221 to 230 of about 549,379 (280)
Mutual shaping of tumor microbiota and TME. Intratumoral microbiota—comprising diverse bacteria, fungi, viruses, and intracellular organisms—play critical and dynamic roles in shaping the tumor microenvironment (TME). Their spatial and compositional diversity contributes to both intratumoral and intertumoral heterogeneity, influencing immune modulation
Zhifei Gao+9 more
wiley +1 more source
Abstract Background Intensity‐modulated brachytherapy (IMBT) employs rotating high‐Z shields during treatment to decrease radiation in certain directions and conform the dose distribution to the target volume. Prototypes for dynamic IMBT have been proposed for prostate, cervical, and rectal cancer.
Björn Morén+3 more
wiley +1 more source
Neoadjuvant Concurrent Chemoradiotherapy in Treating Locally Advanced Rectal Cancer
Chia-Ming Twu+4 more
openalex +1 more source
We present a rare case of mediastinitis caused by a bronchomediastinal fistula due to the aggressive locoregional recurrence of a lung squamous cell carcinoma involving the central airway. Despite initial tumour regression following chemoradiotherapy and durvalumab, rapid regrowth led to airway penetration and mediastinal infection.
Hana Miyasaka+4 more
wiley +1 more source
Concurrent Chemoradiotherapy for Squamous Cell Carcinoma of the Larynx
openaire +3 more sources
The insufficient sensitivity of single circulating tumor DNA (ctDNA)‐molecular residual disease (MRD) prediction remains unresolved and hinders the clinical implementation of ctDNA. Through prospective cohort study, independent validations, and mechanism exploration from peripheral blood and tumor tissue, we demonstrate that ctDNA‐based STK11/KEAP1 ...
Yu Wang+10 more
wiley +1 more source
Renal cysts developed 4 years after starting crizotinib, representing a rare case of late‐onset Crizotinib Associated Renal Cysts (CARCs). Crizotinib dose reduction led to complete cyst regression without compromising tumor control. ABSTRACT Crizotinib, an anaplastic lymphoma kinase (ALK)/ROS1/c‐MET inhibitor, improves outcomes in ALK‐positive non ...
Joon‐Young Yoon+8 more
wiley +1 more source